180 related articles for article (PubMed ID: 20406480)
1. Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.
Vogelaar FJ; Mesker WE; Rijken AM; van Pelt GW; van Leeuwen AM; Tanke HJ; Tollenaar RA; Liefers GJ
BMC Cancer; 2010 Apr; 10():153. PubMed ID: 20406480
[TBL] [Abstract][Full Text] [Related]
2. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
[TBL] [Abstract][Full Text] [Related]
3. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.
Koch M; Kienle P; Hinz U; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
Ann Surg; 2005 Feb; 241(2):199-205. PubMed ID: 15650626
[TBL] [Abstract][Full Text] [Related]
4. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer.
Weitz J; Koch M; Kienle P; Schrödel A; Willeke F; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
Ann Surg; 2000 Jul; 232(1):66-72. PubMed ID: 10862197
[TBL] [Abstract][Full Text] [Related]
5. Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study.
Vogelaar FJ; van Pelt GW; van Leeuwen AM; Willems JM; Tollenaar RA; Liefers GJ; Mesker WE
Cell Oncol (Dordr); 2016 Dec; 39(6):537-544. PubMed ID: 27613548
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.
Wu P; Tang RN; Zou JH; Wang FC
Hepatogastroenterology; 2012 Oct; 59(119):2164-7. PubMed ID: 23178553
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer.
Koch M; Kienle P; Kastrati D; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
Int J Cancer; 2006 Jun; 118(12):3072-7. PubMed ID: 16425256
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
9. Peri-operative filtration of disseminated cytokeratin positive cells in patients with colorectal liver metastasis.
Frühauf NR; Kasimir-Bauer S; Görlinger K; Lang H; Kaudel CP; Kaiser GM; Oldhafer KJ; Broelsch CE
Langenbecks Arch Surg; 2005 Feb; 390(1):15-20. PubMed ID: 15558304
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
[TBL] [Abstract][Full Text] [Related]
11. Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis.
Koch M; Kienle P; Logan E; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schmidt J; Herfarth C; Weitz J
Ann Surg Oncol; 2007 Feb; 14(2):810-7. PubMed ID: 17103077
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
[TBL] [Abstract][Full Text] [Related]
13. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
[TBL] [Abstract][Full Text] [Related]
14. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients.
Hoffmann K; Kerner C; Wilfert W; Mueller M; Thiery J; Hauss J; Witzigmann H
World J Gastroenterol; 2007 Jan; 13(2):257-63. PubMed ID: 17226905
[TBL] [Abstract][Full Text] [Related]
15. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
[TBL] [Abstract][Full Text] [Related]
16. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.
Guller U; Zajac P; Schnider A; Bösch B; Vorburger S; Zuber M; Spagnoli GC; Oertli D; Maurer R; Metzger U; Harder F; Heberer M; Marti WR
Ann Surg; 2002 Dec; 236(6):768-75; discussion 775-6. PubMed ID: 12454515
[TBL] [Abstract][Full Text] [Related]
17. Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.
Brudvik KW; Seeberg LT; Hugenschmidt H; Renolen A; Schirmer CB; Brunborg C; Bjørnbeth BA; Borgen E; Naume B; Waage A; Wiedswang G
Ann Surg Oncol; 2015 Nov; 22(12):4029-37. PubMed ID: 25801354
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival.
Soeth E; Grigoleit U; Moellmann B; Röder C; Schniewind B; Kremer B; Kalthoff H; Vogel I
J Cancer Res Clin Oncol; 2005 Oct; 131(10):669-76. PubMed ID: 16136352
[TBL] [Abstract][Full Text] [Related]
19. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
Retz M; Lehmann J; Röder C; Weichert-Jacobsen K; Loch T; Romahn E; Lühl C; Kalthoff H; Stöckle M
Eur Urol; 2001 May; 39(5):507-15; discussion 516-7. PubMed ID: 11464030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
